{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:42:00Z","timestamp":1777502520243,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.toxicon.2021.09.016","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T02:20:46Z","timestamp":1632709246000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["NPCdc, a synthetic natriuretic peptide, is a substrate to neprilysin and enhances blood pressure-lowering induced by enalapril in 5\/6 nephrectomized rats"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-8957","authenticated-orcid":false,"given":"Regina Souza","family":"Aires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linaldo","family":"Francisco da Silva Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Felipe","family":"Gomes Rebello Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-474X","authenticated-orcid":false,"given":"Marcelo Zaldini","family":"Hernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Ferreira","family":"Machado Marcondes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Karaoglanovic","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Durce","family":"Oliveira da Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-1720","authenticated-orcid":false,"given":"Leucio Duarte","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2021.09.016_bib1","doi-asserted-by":"crossref","first-page":"172780","DOI":"10.1016\/j.ejphar.2019.172780","article-title":"NO mediates the effect of the synthetic natriuretic peptide NPCdc on kidney and aorta in nephrectomized rats","volume":"866","author":"Aires","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.toxicon.2021.09.016_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/BC.2007.048","article-title":"Neprilysin carboxydipeptidase specificity studies and improvement in its detection with fluorescence energy transfer peptides","volume":"388","author":"Barros","year":"2007","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.toxicon.2021.09.016_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2125.1985.tb02687.x","article-title":"Effective dose range of enalapril in mild to moderate essential hypertension","volume":"19","author":"Bergstrand","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.toxicon.2021.09.016_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004872-199207000-00002","article-title":"Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension","volume":"10","author":"Bevan","year":"1992","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.toxicon.2021.09.016_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00210-012-0791-6","article-title":"Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure","volume":"385","author":"Birner","year":"2012","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"9","key":"10.1016\/j.toxicon.2021.09.016_bib6","doi-asserted-by":"crossref","first-page":"F1253","DOI":"10.1152\/ajprenal.00392.2012","article-title":"Target organ cross talk in cardiorenal syndrome: animal models","volume":"303","author":"Bongartz","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrcardio.2016.200","article-title":"Long-term neprilysin inhibition - implications for ARNIs","volume":"14","author":"Campbell","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.toxicon.2021.09.016_bib8","doi-asserted-by":"crossref","first-page":"608512","DOI":"10.1155\/2014\/608512","article-title":"Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat","volume":"2014","author":"Chandran","year":"2014","journal-title":"Oxid Med Cell Longev"},{"issue":"24","key":"10.1016\/j.toxicon.2021.09.016_bib9","doi-asserted-by":"crossref","first-page":"8737","DOI":"10.1073\/pnas.82.24.8737","article-title":"Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide","volume":"82","author":"Connelly","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.toxicon.2021.09.016_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.toxicon.2008.08.014","article-title":"Renal and vascular effects of the natriuretic peptide isolated from Crotalus durissus cascavella venom","volume":"52","author":"Evangelista","year":"2008","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.toxicon.2021.09.016_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mol.104.002436","article-title":"Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize","volume":"67","author":"Fan","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.09.016_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj2840053","article-title":"Secretion of a functional soluble form of neutral endopeptidase-24.11 from a baculovirus-infected insect cell line","volume":"284","author":"Fossiez","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2021.09.016_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13036-017-0093-0","article-title":"Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure","volume":"12","author":"Fu","year":"2018","journal-title":"J. Biol. Eng."},{"issue":"12","key":"10.1016\/j.toxicon.2021.09.016_bib14","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1681\/ASN.V4122023","article-title":"Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury","volume":"4","author":"Griffin","year":"1994","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccl.2005.03.005","article-title":"Relevance of oxidative pathways in the pathophysiology of chronic kidney disease","volume":"23","author":"Himmelfarb","year":"2005","journal-title":"Cardiol. Clin."},{"issue":"1","key":"10.1016\/j.toxicon.2021.09.016_bib16","first-page":"91","article-title":"Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man","volume":"76","author":"Holmes","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6B","key":"10.1016\/j.toxicon.2021.09.016_bib17","first-page":"24S","article-title":"Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists","volume":"87","author":"Johnston","year":"1989","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.toxicon.2021.09.016_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","article-title":"Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis","volume":"119","author":"Kalantar-Zadeh","year":"2009","journal-title":"Circulation"},{"issue":"Suppl. 8","key":"10.1016\/j.toxicon.2021.09.016_bib19","first-page":"20","article-title":"Monitoring of blood volume during haemodialysis treatment of acute renal and multiple organ failures","volume":"11","author":"Katzarski","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.toxicon.2021.09.016_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(88)80375-2","article-title":"Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide","volume":"232","author":"Kenny","year":"1988","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/bj1370489","article-title":"The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border","volume":"137","author":"Kerr","year":"1974","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.toxicon.2021.09.016_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.33549\/physiolres.931461","article-title":"Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure","volume":"58","author":"Krupicka","year":"2009","journal-title":"Physiol. Res."},{"issue":"10","key":"10.1016\/j.toxicon.2021.09.016_bib23","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.toxicon.2021.09.016_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/B978-0-12-381270-4.00019-6","article-title":"ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules","volume":"487","author":"Leaver-Fay","year":"2011","journal-title":"Methods Enzymol."},{"issue":"26","key":"10.1016\/j.toxicon.2021.09.016_bib25","doi-asserted-by":"crossref","first-page":"15620","DOI":"10.1016\/S0021-9258(19)84876-7","article-title":"Fusion of a cleavable signal peptide to the ectodomain of neutral endopeptidase (EC 3.4.24.11) results in the secretion of an active enzyme in COS-1 cells","volume":"264","author":"Lemay","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.toxicon.2021.09.016_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1113\/expphysiol.2005.032995","article-title":"Renal function in juvenile rats subjected to prenatal malnutrition and chronic salt overload","volume":"91","author":"Magalh\u00e3es","year":"2006","journal-title":"Exp. Physiol."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib28","first-page":"165","article-title":"Oxidative stress in chronic kidney disease","volume":"9","author":"Modaresi","year":"2015","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.toxicon.2021.09.016_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-021-02130-1","article-title":"Comparative cardioprotective effects of carvedilol versus atenolol in a rat model of cardiorenal syndrome type 4","author":"Mohamed","year":"2021","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ihj.2016.08.007","article-title":"Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease \u2013 demystifying controversies","volume":"69","author":"Muneer","year":"2017","journal-title":"Indian Heart J."},{"issue":"4","key":"10.1016\/j.toxicon.2021.09.016_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/fca.11.24","article-title":"Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework","volume":"7","author":"Napoli","year":"2011","journal-title":"Future Cardiol."},{"issue":"8663","key":"10.1016\/j.toxicon.2021.09.016_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(89)90714-9","article-title":"Effects of UK 69 578: a novel atriopeptidase inhibitor","volume":"2","author":"Northridge","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2021.09.016_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12882-015-0163-9","article-title":"Plasma levels of natriuretic peptides and development of chronic kidney disease","volume":"16","author":"Ogawa","year":"2015","journal-title":"BMC Nephrol."},{"issue":"2","key":"10.1016\/j.toxicon.2021.09.016_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000020529","article-title":"Renal hemodynamic response to erythropoietin-induced polycythemia in 5\/6 nephrectomized rats is different from normal rats","volume":"6","author":"Paix\u00e3o","year":"1998","journal-title":"Exp. Nephrol."},{"issue":"2","key":"10.1016\/j.toxicon.2021.09.016_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jmb.2009.08.025","article-title":"Structural substrate conditions required for neutral endopeptidase-mediated natriuretic Peptide degradation","volume":"393","author":"Pankow","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2021.09.016_bib37","first-page":"938651","article-title":"Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management","volume":"2011","author":"Pateinakis","year":"2011","journal-title":"Internet J. Nephrol."},{"issue":"5 Pt 2","key":"10.1016\/j.toxicon.2021.09.016_bib38","first-page":"F936","article-title":"ANF secretion and renal responses to volume expansion with equilibrated blood","volume":"255","author":"Paul","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.toxicon.2021.09.016_bib39","doi-asserted-by":"crossref","first-page":"170363","DOI":"10.1016\/j.peptides.2020.170363","article-title":"Circulating products of C-type natriuretic peptide and links with organ function in health and disease","volume":"132","author":"Prickett","year":"2020","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.toxicon.2021.09.016_bib40","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/prot.22716","article-title":"Sub-angstrom modeling of complexes between flexible peptides and globular proteins","volume":"78","author":"Raveh","year":"2010","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.toxicon.2021.09.016_bib41","first-page":"151\u2010163","article-title":"Cardiorenal syndrome in Western countries: epidemiology, diagnosis and management approaches","volume":"2","author":"Ronco","year":"2017","journal-title":"Kidney Dis."},{"issue":"5","key":"10.1016\/j.toxicon.2021.09.016_bib42","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0006-291X(68)90326-4","article-title":"On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain","volume":"32","author":"Schechter","year":"1968","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MAJ.0b013e318271c012","article-title":"Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function","volume":"345","author":"Stavrakis","year":"2013","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.toxicon.2021.09.016_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0022-3565(25)24448-2","article-title":"Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure","volume":"272","author":"Trippodo","year":"1995","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.toxicon.2021.09.016_bib45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jchf.2015.03.011","article-title":"Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure","volume":"3","author":"Vodovar","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.toxicon.2021.09.016_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijcard.2014.08.032","article-title":"Natriuretic peptides and cardio-renal disease","volume":"176","author":"Volpe","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.toxicon.2021.09.016_bib47","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.0000141829.04031.25","article-title":"Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine","volume":"110","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.toxicon.2021.09.016_bib48","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.18632\/aging.103354","article-title":"New insights into the pathophysiological mechanisms underlying cardiorenal syndrome","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"37","key":"10.1016\/j.toxicon.2021.09.016_bib49","doi-asserted-by":"crossref","first-page":"22570","DOI":"10.1074\/jbc.271.37.22570","article-title":"Angiotensin II activation of cyclin D1-dependent kinase activity","volume":"271","author":"Watanabe","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2021.09.016_bib50","first-page":"19B","article-title":"Nesiritide: the clinical experience","volume":"24","author":"Weeks","year":"2008","journal-title":"Can. J. Cardiol."},{"issue":"9","key":"10.1016\/j.toxicon.2021.09.016_bib51","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/00002018-200730090-00004","article-title":"Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure","volume":"30","author":"Yancy","year":"2007","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.toxicon.2021.09.016_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCHEARTFAILURE.108.767483","article-title":"Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial","volume":"1","author":"Yancy","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.toxicon.2021.09.016_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017014521","article-title":"Effect of antihypertensive drug treatment on oxidative stress markers in heart of spontaneously hypertensive rat models","volume":"36","author":"Yusoff","year":"2017","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"9","key":"10.1016\/j.toxicon.2021.09.016_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/nep.12279","article-title":"A practical guide to subtotal nephrectomy in the rat with subsequent methodology for assessing renal and cardiac function","volume":"19","author":"Zhang","year":"2014","journal-title":"Nephrology"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:18:21Z","timestamp":1758575901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010121002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"alternative-id":["S0041010121002646"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.09.016","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NPCdc, a synthetic natriuretic peptide, is a substrate to neprilysin and enhances blood pressure-lowering induced by enalapril in 5\/6 nephrectomized rats","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}